Skip to main content
. 2012 Dec 20;7(12):e48729. doi: 10.1371/journal.pone.0048729

Figure 1. The presence of tumor-reactive TIL is associated to increased PFS and OS.

Figure 1

PFS (A) and OS (B) curves for 47 patients from metastatic melanoma based on the presence of tumor-reactive TIL: cases were divided into two groups, presence of tumor-reactive TIL and absence of tumor-reactive TIL.